TB Drug Repurposing With Network Pharmacology

TB Drug Repurposing with Network Pharmacology, is an authoritative guide that explores the use of network pharmacology and pharmacogenomics for the repurposing of drugs for the treatment of tuberculosis. This book provides an overview of the current state of drug discovery and development for tuberculosis, and highlights the need for new approaches to combat the rising prevalence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB). The book covers various aspects of drug discovery and development for TB, including drug targets, efficacy, safety, toxicity, side effects, and drug interactions. It also discusses the use of drug combinations and synergies to enhance drug efficacy and overcome drug resistance. The book explores the potential of network pharmacology to identify new drug targets and optimize drug combinations for TB treatment. In addition, the book delves into the mechanisms of drug action and resistance, and the importance of host-pathogen interactions in disease pathogenesis. It provides an overview of drug development pipeline, preclinical studies, and clinical trials for TB drug development. Overall, TB Drug Repurposing with Network Pharmacology is an essential resource for researchers, clinicians, and policymakers involved in the fight against tuberculosis. It provides valuable insights into the current challenges and opportunities in TB drug discovery and development, and offers a roadmap for the development of more effective and affordable TB treatments.